Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

detoxification · Mechanism Report

Can these mycotoxins increase oxidative stress, disrupt immune signaling, and injure the gut and mitochondria?

Ochratoxin A, gliotoxin, fumonisins, and trichothecene mycotoxins can increase oxidative stress, disrupt immune signaling, and injure gut and mitochondrial function while raising glutathione-dependent detoxification demand.

PlausibleJuly 17, 202644 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Ochratoxin A, gliotoxin, fumonisins, and trichothecene mycotoxins can increase oxidative stress, disrupt immune signaling, injure gut and mitochondrial function, and increase glutathione-dependent detoxification demand.

laying out figure…
4 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a broad toxic effect from several mycotoxins that converge on cellular stress pathways. The mechanism framing links these exposures to mitochondrial dysfunction, reactive oxygen species production, glutathione depletion, immune signaling changes, and intestinal barrier injury. Together, the graph and conclusion present a connected pattern of oxidative, immune, and gut-related disruption.

Verified conclusion

Exposure to foodborne and environmental mycotoxins—including ochratoxin A (OTA), gliotoxin, fumonisins, and trichothecenes—triggers a cascade of cellular, immunological, and barrier damage.

Cellular and mitochondrial mechanisms

  • Mitochondrial collapse and oxidative stress: These toxins compromise mitochondrial membrane potential, leading to severe ATP depletion and elevated reactive oxygen species (ROS). This structural mitochondrial damage further perpetuates ROS generation, creating a cycle of oxidative stress.
  • Glutathione depletion: The toxins consume intracellular glutathione (GSH) through direct conjugation and oxidation. OTA compounded this by suppressing glutamate-cysteine ligase (GCL, the rate-limiting enzyme in GSH synthesis) and other Nrf2-regulated enzymes, while gliotoxin alters the GSH/GSSG ratio. Supplementation with N-acetylcysteine (NAC) helps rescue cellular viability by restoring GSH pools.
  • Immune signaling disruption: Gliotoxin acts as an immunosuppressor by inhibiting the 20S proteasome, stabilizing I$\kappa$B$\alpha$, and blocking NF-$\kappa$B nuclear translocation. Trichothecenes cause ribotoxic stress, activating mitogen-activated protein kinases (MAPKs like p38, JNK, ERK) and inducing Suppressor of Cytokine Signaling (SOCS) proteins to suppress JAK-STAT pathway activation. OTA similarly impairs IL-2/IL-2 receptor signaling.

Physiological and barrier consequences

  • Gut barrier injury: OTA, fumonisins, and trichothecenes impair the intestinal epithelium (demonstrated by decreased transepithelial electrical resistance) by downregulating, mislocalizing, or degrading essential tight junction proteins, specifically claudins, occludin, and ZO-1. This structural barrier failure is fundamentally driven by mitochondrial ATP depletion, as tight junction maintenance is highly energy-dependent.

Bottom line

  • Ochratoxin A, gliotoxin, fumonisins, and trichothecenes collectively disrupt cellular homeostasis through interconnected pathways: they deplete mitochondrial ATP and glutathione reserves, drive oxidative stress, compromise intestinal tight junctions, and impair critical immune signaling pathways.

References

  1. Ochratoxin A: Toxicity, oxidative stress and metabolism — pubmed.ncbi.nlm.nih.gov ↗
  2. Ochratoxin A: Molecular Interactions, Mechanisms of Toxicity ... — pmc.ncbi.nlm.nih.gov ↗
  3. The Toxic Mechanism of Gliotoxins and Biosynthetic ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  4. Fumonisin Toxicosis and its Effects on Human Health — rsisinternational.org ↗
  5. Elimination of damaged mitochondria through mitophagy reduces mitochondrial oxidative stress and increases tolerance to trichothecenes | PNAS — pnas.org ↗
  6. Antioxidant agents against trichothecenes: new hints for ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  7. World Mycotoxin Journal, 2018; 11 (1): 113-133 — aflatoxinpartnership.org ↗
  8. Reactive oxygen species induced by beauvericin, patulin and zearalenone in CHO-K1 cells - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  9. Effect of Ochratoxin A (OTA) on the Immune System - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  10. Toxic Mechanism and Biological Detoxification of Fumonisins - PMC — pmc.ncbi.nlm.nih.gov ↗
  11. Induction of Suppressors of Cytokine Signaling by the Trichothecene Deoxynivalenol in the Mouse — pmc.ncbi.nlm.nih.gov ↗
  12. Immunotoxic activity of ochratoxin A - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  13. Frontiers | Fungal Toxins and Host Immune Responses — frontiersin.org ↗
  14. Integrated Transcriptional and Proteomic Analysis of Growth Hormone Suppression Mediated by Trichothecene T-2 Toxin in Rat GH3 Cells — academic.oup.com ↗
  15. The intestinal barrier as an emerging target in the toxicological ... — pmc.ncbi.nlm.nih.gov ↗
  16. ��������������������������������������������� — core.ac.uk ↗
  17. Mycotoxins modify the barrier function of Caco-2 cells through differential gene expression of specific claudin isoforms: Protective effect of illite mineral clay - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  18. Porcine intestinal epithelial barrier disruption by the Fusariummycotoxins deoxynivalenol and T-2 toxin promotes transepithelial passage of doxycycline and paromomycin - BMC Veterinary Research — bmcvetres.biomedcentral.com ↗
  19. The effect on the intestine of some fungal toxins: The Trichothecenes — hal.inrae.fr ↗
  20. Progress in Mycotoxins Affecting Intestinal Mucosal Barrier Function — pmc.ncbi.nlm.nih.gov ↗
  21. Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms | American Journal of Physiology-Cell Physiology | American Physiological Society — journals.physiology.org ↗
  22. Modulation of Intestinal Epithelial Permeability in Differentiated Caco-2 Cells Exposed to Aflatoxin M1 and Ochratoxin A Individually or Collectively - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  23. Intestinal Barrier, Claudins and Mycotoxins - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  24. Mycotoxins and the Intestinal Epithelium: From Barrier Injury to Stem ... — pmc.ncbi.nlm.nih.gov ↗
  25. The Compromised Intestinal Barrier Induced by Mycotoxins - PMC — pmc.ncbi.nlm.nih.gov ↗
  26. Deoxynivalenol triggers porcine intestinal tight junction disorder: Insights from mitochondrial dynamics and mitophagy - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  27. Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  28. AHR activation relieves deoxynivalenol-induced disruption of porcine intestinal epithelial barrier functions. — linkinghub.elsevier.com ↗
  29. The intestinal barrier as an emerging target in the toxicological assessment of mycotoxins — link.springer.com ↗
  30. Comparative study of cytotoxicity and oxidative stress ... — pubmed.ncbi.nlm.nih.gov ↗
  31. Gene expression profiling after ochratoxin A treatment in ... — ejast.org ↗
  32. Gene expression profiling after ochratoxin A treatment in ... — pmc.ncbi.nlm.nih.gov ↗
  33. Ochratoxin A causes mitochondrial dysfunction, apoptotic and autophagic cell death and also induces mitochondrial biogenesis in human gastric epithelium cells - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  34. Ochratoxin A-Induced Apoptosis of IPEC-J2 Cells through ROS-Mediated Mitochondrial Permeability Transition Pore Opening Pathway - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  35. Deficient Glutathione in the Pathophysiology of Mycotoxin ... — pmc.ncbi.nlm.nih.gov ↗
  36. Ochratoxin A Induces Oxidative Stress in HepG2 Cells by Impairing ... — pmc.ncbi.nlm.nih.gov ↗
  37. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  38. Glutathione and Glutathione‐ S ‐Transferase in Detoxification Mechanisms — onlinelibrary.wiley.com ↗
  39. Glutathione transferases: substrates, inihibitors and pro- ... — nature.com ↗
  40. Mitochondrial ATP Depletion Disrupts Caco-2 Monolayer Integrity and Internalizes Claudin 7 — journal.frontiersin.org ↗
  41. Mitochondrial ATP Depletion Disrupts Caco-2 Monolayer ... — pmc.ncbi.nlm.nih.gov ↗
  42. Ochratoxin A induces mitochondrial dysfunction, oxidative ... — pmc.ncbi.nlm.nih.gov ↗
  43. Verrucarin A induces apoptosis through ROS-mediated EGFR/ ... — pubmed.ncbi.nlm.nih.gov ↗
  44. Roridin E and satratoxin H, macrocyclic trichothecene ... — sciencedirect.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the GSTP1 rs1695 AG genotype alter glutathione-conjugation activity?→Plausible12 sourcesDo metals and mycotoxins increase demand on glutathione-dependent antioxidant and detoxification pathways?→